E. Fougera OTCs
This article was originally published in The Tan Sheet
Executive Summary
Consumer Products Division will introduce three new OTC products in first aid, athlete's foot areas by mid-2003, company says. Three products will not be Rx switches, but Fougera is "considering additional original developments, transfers from the main line and Rx-to-OTC switch candidates" in the future. Two of newly created division's three original products - HydroZone Plus 1% (hydrocortisone lotion) and babyADE A&D + vitamin E diaper rash ointment - were "an extension of Fougera's Rx experience," firm notes (1"The Tan Sheet" June 3, 2002, In Brief)...
You may also be interested in...
babyADE ointment
E. Fougera & Co., which makes ointments and ophthalmics for the institutional market, continues its foray into the OTC arena with launch of babyADE A&D + Vitamin E diaper rash ointment. Fougera hopes addition of vitamin E to its standard A&D ointment will "attract health aware parents" and "allow mothers to continue using the diaper rash ointment they were introduced to in the hospital after they go home." Hitting independent drugstore shelves now, babyADE is available in 2 oz. tubes for $3.99-$4.99, 4 oz. tubes for $5.49-$6.99. Firm notes "deals are imminent" to launch ointment in two major national drug chains, with national distribution expected by early 2003...
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.